Bank of America Global Healthcare Conference 2026 May 12, 2026 6:00 PM EDTCompany ParticipantsRoland Sackers - CFO, MD & Member ...
The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. ("Qiagen" or the "Company") (NYSE:QGEN). The investigation concerns whether the Company a ...
The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Qiagen N.V. (“Qiagen” or the “Company ...
The average one-year price target for Qiagen N.V. (NYSE:QGEN) has been revised to $46.28 / share. This is a decrease of 13.91 ...
Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand ...
1d
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight
The cervical cancer diagnostics market is witnessing significant growth due to the rising prevalence of cervical cancer and increasing awareness regarding early screening and diagnosis. Growing ...
Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. ("Amplitude" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...
Pomerantz LLP is investigating claims on behalf of investors of Merchants Bancorp ("Merchants Bancorp" or the "Company") . Such investors are advised to contact Danielle Peyton at ...
The global DNA Polymerase Market is projected to expand from USD 397.7 million in 2025 to USD 725.8 million by 2035, growing ...
Builds on approximately $300 million returned to shareholders in early 2024 as part of commitment to return at least $1 billion through end-2028 VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results